Healthcare & Pharmaceuticals
The Indian Pharma Market (IPM) was estimated at ~USD 15 bn in 2016 (MAT March 2016) and has grown at a CAGR of ~11% in the last 3 years. While the Drug Price Control Order 2013 brought additional drugs under the ambit of price control and revised prices downwards, Pharma companies have held up owing to strong volume growth and new product introductions. IPM is a huge market being the third largest in terms of volume and 13th largest in terms of value. The market also offers high growth potential with the long-term strategic growth of the Indian pharma industry being pegged at ~15% p.a.
For the sake of highlighting the real activity in this sector, we, at Aurum, have classified this sector under five major sub-sections: